Provided by Tiger Trade Technology Pte. Ltd.

Inozyme Pharma

4.00
0.0000
Volume:- -
Turnover:5.83M
Market Cap:259.66M
PE:-2.38
High:4.00
Open:4.00
Low:4.00
Close:4.00
52wk High:6.24
52wk Low:0.7210
Shares:64.92M
Float Shares:30.15M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6822
EPS(LYR):-1.6243
ROE:-141.69%
ROA:-48.45%
PB:8.17
PE(LYR):-2.46

Loading ...

BioMarin Raises 2025 Revenue Guidance as PALYNZIQ and VOXZOGO Sales Climb 20%

Reuters
·
Oct 28

BioMarin updates financial impact of Inozyme Pharma acquisition with estimated 221 million charge in Q3 2025

Reuters
·
Oct 08

BioMarin Reports Q2 2025 Revenue of $825M, GAAP EPS Up 124% Y/Y, Raises Full-Year 2025 Guidance

Reuters
·
Aug 05

Inozyme Pharma Inc. Announces Delisting from Nasdaq and Deregistration of Shares Following Merger

Reuters
·
Jul 01

BioMarin Pharmaceutical Closes Acquisition of Inozyme Pharma

MT Newswires Live
·
Jul 01

Trading in risky penny stocks is booming. Why it could be a sign of trouble ahead for the market.

Dow Jones
·
Jul 01

Press Release: Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

Dow Jones
·
Jun 21

Inozyme Pharma Announces Transaction Bonuses for Key Executives Following Merger Agreement

Reuters
·
Jun 02

Raymond James Downgrades Inozyme Pharma to Market Perform From Outperform

MT Newswires Live
·
May 19

U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma

Reuters
·
May 19

Inozyme Pharma Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
May 17

Sector Update: Health Care Stocks Rise Friday Afternoon

MT Newswires Live
·
May 17

Inozyme Pharma Cut to Hold From Buy by Needham

Dow Jones
·
May 17

Wells Fargo Downgrades Inozyme Pharma to Equal Weight From Overweight, $4 Price Target

MT Newswires Live
·
May 16

Inozyme Shares More Than Double in Surge Toward BioMarin's Buyout Price

Dow Jones
·
May 16

US Stocks Edge Higher; Consumer Sentiment Falls In May

Benzinga
·
May 16

Wedbush Downgrades Inozyme Pharma to Neutral From Outperform, Adjusts Price Target to $4 From $7

MT Newswires Live
·
May 16

BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, Charter Communications, Vistra

Reuters
·
May 16

BUZZ-Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin

Reuters
·
May 16

BioMarin Pharmaceutical to Acquire Inozyme Pharma for $270 Million

MT Newswires Live
·
May 16